"Enabling Genomics in Routine Medical Care"
The DxTerity technology, DxDirect™, is a simple, fast and affordable technique for analysis of complex gene signatures. DxDirect™ combines a robust chemical ligation process, NEAT™, and a unique sample stabilization system, DxCollect™. This enable direct from whole blood or tissue sample multiplex gene expression testing without many of the constraints that exist today.
1. Two chemically reactive probes per target which is unique for each gene target.
Testing which once could only be done by a sophisticated research lab, or highly specialized and high skilled area within a clinical lab, can now be performed reliably in a routine manner by lab technicians and clinicians, all with the same level of quality.


| Chemistry Flyer Overview of the DxDirect Chemistry and Performance read more... |
|||
|
Chemistry White Paper (DxDirect) |
|||
| |
American Association of Cancer Research Data and Background on DxDirect™ and NEAT™ read more... |
|
DxTerity Presents Direct from Sample Mulitplex Gene Expression in Tissue and FFPE to the American Association of Cancer Researchers read more...
DxTerity wins program with NCI to improve FFPE QC for in situ processing read more...